Abstract
Background: TGFB1 cytokine is involved in normal mammary epithelial development as well as in breast tumorigenesis. It has role in both breast tumor suppression and progression. TGFB1 gene has several single nucleotide polymorphisms (SNPs) many of which modulate the activity of TGFB1. Our aim in this study was to analyze TGFB1 + 29 polymorphism in breast cancer individuals from North Indian population. Methods: TGFB1 + 29 T/C polymorphism was analyzed using Sanger sequencing in 285 breast cancer patients and age matched 363 healthy controls from North Indian population. Next, transcript expression of 13 apoptotic genes, TRAIL, DR4, DR5, DcR1, DcR2, Bcl2, cytochrome c, Casp8L, Casp8, FlipS, FlipL, Casp3s and Casp3 were carried out in 77 breast tumor tissues obtained from 77 individuals. Results: TGFB1 + 29 CC genotype provided protection against the development of breast cancer (P = 0.012). This was mainly attributable to higher age group (> 45 years) women (P = 0.016). Individuals having CC protector genotype showed significantly higher expression of TGFB1 transcript compared to the TT and TC risk genotypes (P = 0.044). Furthermore, we observed that TGFB1 + 29 CC genotype showed increased TRAIL mediated apoptosis via the extrinsic pathway in breast tumor patients with age greater than 45 years (P = 0.027). Conclusion: TGFB1 + 29 homozygous mutant CC genotype is related to protection against breast cancer in North Indian women population greater than 45 years of age.
Similar content being viewed by others
Data Availability
The data that supports the findings of this study are available from the corresponding author, RP, upon reasonable request.
References
Muraoka-Cook, R. S., Dumont, N., & Arteaga, C. L. (2005).Clin Cancer Res11,937s-943s
Dranoff, G. (2004).Nat Rev Cancer4,11–22
Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018).Bone Res6,2
Goumans, M. J., Liu, Z., & ten Dijke, P. (2009).Cell Res19,116–127
Hata, A., & Chen, Y. G. (2016).Cold Spring Harb Perspect Biol8
Massague, J. (2012).Nat Rev Mol Cell Biol13,616–630
Roberts, A. B., & Wakefield, L. M. (2003).Proc Natl Acad Sci U S A100,8621–8623
Seoane, J., & Gomis, R. R. (2017).Cold Spring Harb Perspect Biol9
Ahn, Y. O., Lee, J. C., Sung, M. W., & Heo, D. S. (2009).J Immunol182,6114–6120
Khoshakhlagh, M., Soleimani, A., Binabaj, M. M., Avan, A., Ferns, G. A., Khazaei, M., & Hassanian, S. M. (2019).Biochem Pharmacol164,17–22
Moore-Smith, L. D., Isayeva, T., Lee, J. H., Frost, A., & Ponnazhagan, S. (2017).Sci Rep7,8678
Falschlehner, C., Emmerich, C. H., Gerlach, B., & Walczak, H. (2007).Int J Biochem Cell Biol39,1462–1475
Johnstone, R. W., Frew, A. J., & Smyth, M. J. (2008).Nat Rev Cancer8,782–798
Ashkenazi, A. (2008).Nat Rev Drug Discov7,1001–1012
Himeji, D., Horiuchi, T., Tsukamoto, H., Hayashi, K., Watanabe, T., & Harada, M. (2002). Blood 99, 4070–4078
Vegran, F., Boidot, R., Oudin, C., Riedinger, J. M., Bonnetain, F., & Lizard-Nacol, S. (2006).Clin Cancer Res12,5794–5800
Herzer, K., Ganten, T. M., Schulze-Bergkamen, H., Grosse-Wilde, A., Koschny, R., Krammer, P. H., & Walczak, H. (2005).Hepatology42,183–192
Sanchez-Capelo, A. (2005).Cytokine Growth Factor Rev16,15–34
Saltzman, A., Munro, R., Searfoss, G., Franks, C., Jaye, M., & Ivashchenko, Y. (1998).Exp Cell Res242,244–254
Shima, Y., Nakao, K., Nakashima, T., Kawakami, A., Nakata, K., Hamasaki, K., Kato, Y., Eguchi, K., & Ishii, N. (1999).Hepatology30,1215–1222
Cao, Y., Chen, L., Zhang, W., Liu, Y., Papaconstantinou, H. T., Bush, C. R., Townsend, C. M. Jr., Thompson, E. A., & Ko, T. C. (2007).Am J Physiol Gastrointest Liver Physiol292,G28-38
Lafon, C., Mathieu, C., Guerrin, M., Pierre, O., Vidal, S., & Valette, A. (1996).Cell Growth Differ7,1095–1104
Cano-Gonzalez, A., & Lopez-Rivas, A. (2016).Biochim Biophys Acta1863,2104–2114
Bedi, A., Chang, X., Noonan, K., Pham, V., Bedi, R., Fertig, E. J., Considine, M., Califano, J. A., Borrello, I., Chung, C. H., Sidransky, D., & Ravi, R. (2012).Mol Cancer Ther11,2429–2439
Zhang, S., Ekman, M., Thakur, N., Bu, S., Davoodpour, P., Grimsby, S., Tagami, S., Heldin, C. H., & Landstrom, M. (2006).Cell Cycle5,2787–2795
Li, Y., Liu, Y., Chiang, Y. J., Huang, F., Li, Y., Li, X., Ning, Y., Zhang, W., Deng, H., & Chen, Y. G. (2019).Cell Rep28,735–745e734
Kim, M. R., Lee, J., An, Y. S., Jin, Y. B., Park, I. C., Chung, E., Shin, I., Barcellos-Hoff, M. H., & Yi, J. Y. (2015).Mol Cancer Res13,319–329
Davies, A. A., Masson, J. Y., McIlwraith, M. J., Stasiak, A. Z., Stasiak, A., Venkitaraman, A. R., & West, S. C. (2001).Mol Cell7,273–282
Li, J., Zhu, H., Chen, T., Dai, G., & Zou, L. (2011).Cell Biochem Biophys60,245–248
Lin, W. W., & Karin, M. (2007).J Clin Invest117,1175–1183
Wang, L., Tong, X., Zhou, Z., Wang, S., Lei, Z., Zhang, T., Liu, Z., Zeng, Y., Li, C., Zhao, J., Su, Z., Zhang, C., Liu, X., Xu, G., & Zhang, H. T. (2018).Mol Cancer17,140
Wu, Y., Zhao, J., & He, M. (2015).Tumour Biol36,5149–5156
Colakogullari, M., Ulukaya, E., Yilmaztepe Oral, A., Aymak, F., Basturk, B., Ursavas, A., & Oral, H. B. (2008).Cell Biochem Funct26,283–290
Alqumber, M. A., Dar, S. A., Haque, S., Wahid, M., Singh, R., & Akhter, N. (2014).Asian Pac J Cancer Prev15,8725–8734
Huang, Y., Li, B., Qian, J., Xie, J., & Yu, L. (2010).Breast Cancer Res Treat123,863–868
Krishna, B. M., Jana, S., Panda, A. K., Horne, D., Awasthi, S., Salgia, R., & Singhal, S. S. (2020). Cancers (Basel) 12
Ziv, E., Cauley, J., Morin, P. A., Saiz, R., & Browner, W. S. (2001).JAMA285,2859–2863
Pal, R., Gochhait, S., Chattopadhyay, S., Gupta, P., Prakash, N., Agarwal, G., Chaturvedi, A., Husain, N., Husain, S. A., & Bamezai, R. N. (2011).Breast Cancer Res Treat126,333–343
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002).Genome Biol3,RESEARCH0034
Dunning, A. M., Ellis, P. D., McBride, S., Kirschenlohr, H. L., Healey, C. S., Kemp, P. R., Luben, R. N., Chang-Claude, J., Mannermaa, A., Kataja, V., Pharoah, P. D., Easton, D. F., Ponder, B. A., & Metcalfe, J. C. (2003).Cancer Res63,2610–2615
Hishida, A., Iwata, H., Hamajima, N., Matsuo, K., Mizutani, M., Iwase, T., Miura, S., Emi, N., Hirose, K., & Tajima, K. (2003).Breast Cancer10,63–69
Gonzalez-Zuloeta Ladd, A. M., Arias-Vasquez, A., Siemes, C., Coebergh, J. W., Hofman, A., Witteman, J., Uitterlinden, A., Stricker, B. H., & van Duijn, C. M. (2007).Eur J Cancer43,371–374
Lee, K. M., Park, S. K., Hamajima, N., Tajima, K., Yoo, K. Y., Shin, A., Noh, D. Y., Ahn, S. H., Hirvonen, A., & Kang, D. (2005).Breast Cancer Res Treat90,149–155
Pooja, S., Francis, A., Rajender, S., Tamang, R., Rajkumar, R., Saini, K. S., Megu, K., Goel, M. M., Surekha, D., Rao, D. R., Rao, L., Ramachandra, L., Kumar, S., Kumar, S., Vishnupriya, S., Satyamoorthy, K., Negi, M. P., Thangaraj, K., & Konwar, R. (2013).PLoS One8,e75979
Yokota, M., Ichihara, S., Lin, T. L., Nakashima, N., & Yamada, Y. (2000).Circulation101,2783–2787
Arteaga, C. L., Dugger, T. C., & Hurd, S. D. (1996).Breast Cancer Res Treat38,49–56
Reiss, M., & Barcellos-Hoff, M. H. (1997).Breast Cancer Res Treat45,81–95
Pasche, B., Kolachana, P., Nafa, K., Satagopan, J., Chen, Y. G., Lo, R. S., Brener, D., Yang, D., Kirstein, L., Oddoux, C., Ostrer, H., Vineis, P., Varesco, L., Jhanwar, S., Luzzatto, L., Massague, J., & Offit, K. (1999).Cancer Res59,5678–5682
Tang, B., Bottinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J., Anver, M. R., Letterio, J. J., & Wakefield, L. M. (1998).Nat Med4,802–807
Zheng, W. (2009).Methods Mol Biol472,265–277
Anderson, W. F., Pfeiffer, R. M., Dores, G. M., & Sherman, M. E. (2006).Cancer Epidemiol Biomarkers Prev15,1899–1905
Balducci, L., & Beghe, C. (2001).Crit Rev Oncol Hematol37,137–145
Ershler, W. B., & Longo, D. L. (1997).J Natl Cancer Inst89,1489–1497
Acknowledgements
We thank Prof. R.N.K Bamezai (Jawaharlal Nehru University, New Delhi, India) for providing research facilities for carrying out the research work, critically reading and commenting on the manuscript which is based on the thesis work of RP carried out at Jawaharlal Nehru University, New Delhi, India (http://hdl.handle.net/10603/14169). We acknowledge Dr. Pawan Gupta of Dharamshila Cancer Hospital and Research Centre, Delhi, Dr. Neeraj Prakash from Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India and Dr. Gaurav Agarwal from Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India for providing the authors with the samples to carry out the research work in breast cancer biology. The authors further thank the patient and control subjects for their participation.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Jawaharlal Nehru University.
Informed Consent
was obtained from all individual participants included in the study.
Competing Interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Supplementary Fig. 1
Categorization of gene expression belonging to extrinsic and intrinsic apoptotic pathways (TRAIL, DR4, DR5, Casp8, Casp3, TRAIL, DcR1, DcR2, Casp8L, FlipL, FlipS, Casp3s, Cytochrome c, Casp3, Bcl2, Casp3s) with respect to age (≤ 45 and > 45 years) which are further categorized with respect to TGFB1 + 29 genotype. * indicates p value less than equal to 0.05. # indicates p value less than equal to 0.09 but more than 0.05. Error bars represents standard error.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pal, R., Dutta, S. Association Study of Transforming Growth Factor Beta 1 + 29 T/C exon 1 Polymorphism in Breast Cancer Patients from North Indian Population. Appl Biochem Biotechnol 195, 3671–3680 (2023). https://doi.org/10.1007/s12010-023-04438-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-023-04438-5